Leukemia, Myelodysplasia, Transplantation


Ponatinib trials put on partial hold

The US Food and Drug Administration (FDA) has paused new enrollment in the trials. Patients already enrolled will continue to receive ponatinib,...


Drug gets orphan designation for MDS

The drug, CPI-613, targets metabolic changes that are thought to occur in many cancer cells. It has demonstrated activity and tolerability in a...